View in EDS HTML Full Text PDF Full Text

A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.

Saved in:
Bibliographic Details
Title: A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Authors: Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee, USA dspigel@tnonc.com.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Shipley DL; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Waterhouse DM; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Jones SF; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Ward PJ; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Shih KC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hemphill B; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., McCleod M; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Ft. Myers Florida, USA., Whorf RC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Bradenton, Florida, USA., Page RD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Center for Cancer and Blood Disorders, Ft. Worth, Texas, USA., Stilwill J; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Research Medical Center, Kansas City, Missouri, USA., Mekhail T; Florida Hospital Cancer Institute, Orlando, Florida, USA., Jacobs C; Oncogenex, Bothell, Washington, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hainsworth JD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
Source: The oncologist [Oncologist] 2019 Dec; Vol. 24 (12), pp. e1409-e1416. Date of Electronic Publication: 2019 Aug 16.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31420467
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spigel+DR%22">Spigel DR</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA dspigel@tnonc.com.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Shipley+DL%22">Shipley DL</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Waterhouse+DM%22">Waterhouse DM</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Jones+SF%22">Jones SF</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Ward+PJ%22">Ward PJ</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Shih+KC%22">Shih KC</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Hemphill+B%22">Hemphill B</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22McCleod+M%22">McCleod M</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Ft. Myers Florida, USA.<br /><searchLink fieldCode="AU" term="%22Whorf+RC%22">Whorf RC</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Bradenton, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Page+RD%22">Page RD</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Center for Cancer and Blood Disorders, Ft. Worth, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Stilwill+J%22">Stilwill J</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Research Medical Center, Kansas City, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Mekhail+T%22">Mekhail T</searchLink>; Florida Hospital Cancer Institute, Orlando, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+C%22">Jacobs C</searchLink>; Oncogenex, Bothell, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Hainsworth+JD%22">Hainsworth JD</searchLink>; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2019 Dec; Vol. 24 (12), pp. e1409-e1416. <i>Date of Electronic Publication: </i>2019 Aug 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31420467
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1634/theoncologist.2018-0518
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1409
    Titles:
      – TitleFull: A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spigel DR
      – PersonEntity:
          Name:
            NameFull: Shipley DL
      – PersonEntity:
          Name:
            NameFull: Waterhouse DM
      – PersonEntity:
          Name:
            NameFull: Jones SF
      – PersonEntity:
          Name:
            NameFull: Ward PJ
      – PersonEntity:
          Name:
            NameFull: Shih KC
      – PersonEntity:
          Name:
            NameFull: Hemphill B
      – PersonEntity:
          Name:
            NameFull: McCleod M
      – PersonEntity:
          Name:
            NameFull: Whorf RC
      – PersonEntity:
          Name:
            NameFull: Page RD
      – PersonEntity:
          Name:
            NameFull: Stilwill J
      – PersonEntity:
          Name:
            NameFull: Mekhail T
      – PersonEntity:
          Name:
            NameFull: Jacobs C
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
      – PersonEntity:
          Name:
            NameFull: Hainsworth JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2019 Dec
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1